Press release
Global Factors Driving the Rapid Evolution of the Veterinary Autoimmune Disease Therapeutics Market
Veterinary Autoimmune Disease Therapeutics Market
Projected Market Value and Growth Outlook for Veterinary Autoimmune Disease Therapeutics
The veterinary autoimmune disease therapeutics market is anticipated to reach a valuation of $4.61 billion by 2030, growing steadily at a compound annual growth rate (CAGR) of 5.8%. This upward trajectory is fueled by progress in immunomodulatory therapies and the development of new oral and injectable formulations. Additionally, increasing recognition of autoimmune diseases in companion animals and the expansion of veterinary hospitals and clinics contribute to this growth. Precision medicine approaches are also becoming more widely adopted, enhancing treatment effectiveness and compliance.
Download a free sample of the veterinary autoimmune disease therapeutics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16208&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Factors Fueling Growth in Veterinary Autoimmune Disease Therapeutics - Part One
One significant factor boosting this market is the advancement of immunomodulatory therapies, which help regulate immune system responses more effectively in animals. Alongside this, the introduction of novel oral and injectable drug formulations facilitates easier administration and improved treatment adherence, especially in companion animals affected by autoimmune conditions.
Factors Fueling Growth in Veterinary Autoimmune Disease Therapeutics - Part Two
Another key driver is the rise in awareness about autoimmune diseases among pet owners and veterinarians, which is leading to earlier diagnosis and better management. Meanwhile, the ongoing expansion of veterinary hospital and clinic networks globally provides more access to specialized care, supporting the demand for advanced autoimmune disease treatments.
View the full veterinary autoimmune disease therapeutics market report:
https://www.thebusinessresearchcompany.com/report/veterinary-autoimmune-disease-therapeutics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Key Industry Leaders in the Veterinary Autoimmune Disease Therapeutics Market
The market is shaped by several prominent companies, including Pfizer Inc, Merck & Co Inc, AbbVie Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline, Takeda Pharmaceutical Company, Amgen Inc., Teva Pharmaceuticals Industries Ltd., Zoetis Inc, Boehringer Ingelheim International GmbH, Sumitomo Pharma Co. Ltd., IDEXX Laboratories Inc., Cipla Inc., Mallinckrodt Pharmaceuticals, Virbac S.A, Dechra Pharmaceuticals plc, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Heska Corporation, Bimeda Holdings PLC, Bayer Animal Health Inc, Aratana Therapeutics Inc, and Hester Biosciences Limited.
Significant Acquisition Highlighting Market Expansion
In March 2024, AbbVie Inc., a US-based biopharmaceutical firm known for addressing complex health challenges, acquired Landos Biopharma for $137.5 million. This move aims to strengthen AbbVie's portfolio in inflammatory bowel diseases by advancing innovative therapies like NX-13, which may also have applications in veterinary autoimmune treatment. Landos Biopharma focuses on developing autoimmune therapies that could be used across both human and animal health sectors.
Emerging Advancements and Strategic Moves in Veterinary Autoimmune Disease Therapeutics
Leading players in this market are honing in on innovative solutions to meet pressing needs. For example, RenBiologics is developing cutting-edge therapies targeting kidney-related and chronic diseases with biologics and regenerative medicine. In January 2024, Biocytogen, a biotechnology company from China, launched RenBiologics as a sub-brand to out-license fully human antibodies for therapeutic development. Their extensive library of over 400,000 antibody sequences, generated through proprietary RenMice platforms, enables partnerships with pharma and biotech companies, accelerating the creation of new antibody-based treatments. This development underscores the commitment towards rapid innovation in veterinary autoimmune therapeutics.
Breakdown of Veterinary Autoimmune Disease Therapeutics Market Segments
This market is categorized across multiple segments for a detailed analysis:
1) Therapy Type: corticosteroids, azathioprine, cyclosporine, mycophenolate, leflunomide, cyclophosphamide
2) Animal Type: companion animals, livestock animals, other animal types
3) Disease: hypothyroidism, pemphigus disease, canine lupus, autoimmune hemolytic anemia, bullous pemphigoid, discoid lupus erythematosus (DLE), immune-related arthritis, and other diseases
4) Distribution Channel: veterinary hospitals and veterinary clinics
Detailed Subcategories Within Therapies
Therapies are further divided into specific formulations, such as:
- Corticosteroids: prednisone, prednisolone, dexamethasone, methylprednisolone, triamcinolone
- Azathioprine: oral tablets and injectable formulations
- Cyclosporine: oral cyclosporine (Atopica) and injectable forms
- Mycophenolate: oral mycophenolate mofetil and injectable mycophenolate sodium
- Leflunomide: oral tablets and injectable forms
- Cyclophosphamide: oral and injectable options
This comprehensive segmentation highlights the diverse treatment options available for managing veterinary autoimmune diseases, catering to different animal types and clinical needs.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Factors Driving the Rapid Evolution of the Veterinary Autoimmune Disease Therapeutics Market here
News-ID: 4459266 • Views: …
More Releases from The Business Research Company
Segmentation, Major Trends, and Competitive Overview of the Veterinary Surgical …
The veterinary surgical instruments market is poised for significant expansion as advancements in animal healthcare continue to accelerate. With a rising demand for specialized surgeries and precision tools, this sector is set to experience robust growth in the coming years. Let's explore the expected market size, main players, emerging trends, and key segmentation that define this dynamic industry.
Projected Market Size and Growth of the Veterinary Surgical Instruments Market
The…
Overview of Segmentation, Market Dynamics, and Competitive Landscape in the Vete …
The veterinary anti-infectives sector is on track for substantial expansion as demand for specialized animal healthcare solutions continues to rise. Driven by advancements in treatment options and growing awareness of animal health, this market is expected to witness remarkable growth over the coming years. Here's a detailed overview of its size, key players, emerging trends, and defining segments.
Market Size and Growth Outlook for the Veterinary Anti-infectives Market
The veterinary…
Leading Companies Propelling Innovation and Growth in the Veterinary Reference L …
The veterinary reference laboratory market is on track for significant expansion as technological advances and growing demand for animal health services drive industry growth. With rising awareness of animal diagnostics and preventive care, this sector is poised to experience rapid development over the coming years. Here is an overview of the market's future size, key players, emerging trends, and detailed segment insights shaping its trajectory.
Projected Growth and Market Size of…
Analysis of Key Market Segments Influencing the Swine Feed Minerals Market
The swine feed minerals market is attracting significant attention as demand for improved animal nutrition intensifies worldwide. With evolving consumer preferences and advances in feed technology, this sector is set to experience substantial growth over the coming years. Let's explore the market's size, key players, emerging trends, and segmentation to understand the promising outlook ahead.
Projected Expansion of the Swine Feed Minerals Market by 2030
The swine feed minerals market…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
